Showing results (261-270 of 353) with videos related to
Sort By:
Pageof 36
European Heart Journal|October 8, 2020
Validation of high bleeding risk criteria and definition as proposed by the academic research consortium for high bleeding riskNoé Corpataux, Alessandro Spirito, Felice Gragnano, et al.Lancet (London, England)|April 7, 2022
Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trialFelix Mahfoud, David E Kandzari, Kazuomi Kario, et al.Journal of the American Heart Association|June 8, 2021
Sex-Based Differences in Bleeding Risk After Percutaneous Coronary Intervention and Implications for the Academic Research Consortium High Bleeding Risk CriteriaAlessandro Spirito, Felice Gragnano, Noé Corpataux, et al.Journal of the American College of Cardiology|May 6, 2021
Changes in Plasma Renin Activity After Renal Artery Sympathetic DenervationFelix Mahfoud, Raymond R Townsend, David E Kandzari, et al.American Heart Journal|June 5, 2017
Use of prasugrel vs clopidogrel and outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention in contemporary clinical practice: Results from the PROMETHEUS studyUsman Baber, Samantha Sartori, Melissa Aquino, et al.Journal of the American College of Cardiology|April 16, 2016
Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARISUsman Baber, Roxana Mehran, Gennaro Giustino, et al.JACC. Cardiovascular Interventions|August 7, 2017
Associations Between Chronic Kidney Disease and Outcomes With Use of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Report From the PROMETHEUS StudyUsman Baber, Jaya Chandrasekhar, Samantha Sartori, et al.European Heart Journal. Acute Cardiovascular Care|July 17, 2023
Thrombotic risk in patients with acute coronary syndromes discharged on prasugrel or clopidogrel: results from the PROMETHEUS studyMauro Chiarito, Davide Cao, Samantha Sartori, et al.Journal of Thrombosis and Thrombolysis|March 30, 2019
Associations between use of prasugrel vs clopidogrel and outcomes by type of acute coronary syndrome: an analysis from the PROMETHEUS registryZhen Ge, Usman Baber, Bimmer E Claessen, et al.European Heart Journal. Cardiovascular Pharmacotherapy|July 16, 2016
Assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversionFaiez Zannad, Wendy Gattis Stough, Raymond J Lipicky, et al.Pageof 36